Scientists at Israel’s Weizmann Institute have discovered that the dendritic immune cell cDC1 increases the severity of fatty liver disease and NASH, suffered by 90% of obese individuals. The discovery may lead to treatments that could benefit millions of patients.
The immune cells that accelerate liver disease
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.